IMMUNOGLOBULIN A (IGA) NEPHROPATHY
Clinical trials for IMMUNOGLOBULIN A (IGA) NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGLOBULIN A (IGA) NEPHROPATHY trials appear
Sign up with your email to follow new studies for IMMUNOGLOBULIN A (IGA) NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for transplant patients: drug targets kidney damage
Disease control Recruiting nowThis study tests a drug called sparsentan in 20 adults who have protein in their urine after a kidney transplant due to IgA nephropathy or FSGS. Participants take one pill daily for 36 weeks to see if it safely lowers protein levels and protects kidney function. The goal is to co…
Matched conditions: IMMUNOGLOBULIN A (IGA) NEPHROPATHY
Phase: PHASE4 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 07:34 UTC
-
Gene therapy trial offers new hope for kidney disease patients
Disease control Recruiting nowThis study tests a new gene therapy, PS-002, for adults with IgA nephropathy, a kidney disease that can lead to kidney failure. The treatment is given as a single dose and aims to slow or stop the disease. The study includes 32 people who are at high risk of their disease getting…
Matched conditions: IMMUNOGLOBULIN A (IGA) NEPHROPATHY
Phase: PHASE1, PHASE2 • Sponsor: Purespring Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 07:34 UTC